U.S. Appeals Court Revives 100s of Tylenol Autism Lawsuits Over Pregnancy Use
Updated
Updated · The New York Times · Jul 13
U.S. Appeals Court Revives 100s of Tylenol Autism Lawsuits Over Pregnancy Use
3 articles · Updated · The New York Times · Jul 13
Summary
Hundreds of lawsuits against Tylenol makers can proceed after a U.S. appeals court reversed a trial judge’s dismissal of claims linking prenatal acetaminophen use to autism and A.D.H.D.
The panel said the lower court overstepped by excluding plaintiffs’ expert evidence, ruling that testimony on the alleged link was admissible because the science remains disputed.
Andrea Baccarelli, dean of Harvard’s public health school, was the plaintiffs’ main expert and argued substantial evidence supports a causal link, especially with frequent high-dose use during pregnancy.
Major medical groups still say Tylenol is the safest pain and fever option in pregnancy, noting untreated fevers can endanger both mother and fetus, while large studies have found no causal link.
If these lawsuits succeed, could America's most common pain reliever soon require a major pregnancy warning?
When does a scientific debate become a multi-million dollar question for a jury to decide?
Tylenol Lawsuits Revived: Appeals Court Reopens Thousands of Autism and ADHD Claims Amid Ongoing Scientific Uncertainty
Overview
A U.S. federal appeals court has revived lawsuits claiming that taking Tylenol (acetaminophen) during pregnancy can cause neurodevelopmental disorders like autism and ADHD in children. This issue gained major public attention after President Donald Trump and health officials suggested a possible link, but scientific evidence for a direct connection remains unproven. While some studies show a small increase in risk, larger trials that consider genetics and other factors have not found conclusive proof that Tylenol causes these disorders. The revived lawsuits highlight the ongoing debate between public concern, political influence, and the current limits of scientific research.